CLOPIDOGREL BISULFATE

CLOPIDOGREL BISULFATE was reported 103431 times

CLOPIDOGREL BISULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 122 0.6816
1 EOSINOPHILIC BRONCHITIS 83 0.4150
2 VASCULAR STENT THROMBOSIS 654 0.3211
3 INSULIN AUTOIMMUNE SYNDROME 94 0.2633
4 SPINAL EPIDURAL HAEMATOMA 152 0.2581
5 VASCULAR STENT STENOSIS 79 0.1876
6 CORONARY ARTERY RESTENOSIS 89 0.1488
7 RESPIRATORY TRACT HAEMORRHAGE 84 0.1407
8 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1201 0.1357
9 VASCULAR PSEUDOANEURYSM 212 0.1216
10 HYPHAEMA 62 0.1188
11 THROMBOSIS IN DEVICE 371 0.1131
12 ARTERIAL HAEMORRHAGE 119 0.1041
13 OBSTRUCTIVE SLEEP APNOEA SYNDROME 151 0.1035
14 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 62 0.0966
15 MYOGLOBIN BLOOD INCREASED 138 0.0902
16 EXTRADURAL HAEMATOMA 119 0.0899
17 HAEMATOMA MUSCLE 105 0.0876
18 BLOOD LOSS ANAEMIA 194 0.0856
19 ARTERIAL STENOSIS 74 0.0844
20 ACQUIRED HAEMOPHILIA 83 0.0828
21 CORONARY ARTERY STENOSIS 413 0.0820
22 RETROPERITONEAL HAEMATOMA 174 0.0787
23 CAROTID ARTERIOSCLEROSIS 81 0.0785
24 CORONARY ARTERY THROMBOSIS 158 0.0783
25 HYPERPARATHYROIDISM SECONDARY 192 0.0766
26 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 81 0.0763
27 MELAENA 1605 0.0729
28 HAEMORRHAGIC TRANSFORMATION STROKE 108 0.0717
29 NEPHROGENIC ANAEMIA 329 0.0710
30 SYSTOLIC DYSFUNCTION 73 0.0693
31 OESOPHAGEAL SPASM 126 0.0683
32 RETROPERITONEAL HAEMORRHAGE 165 0.0668
33 PERICARDIAL HAEMORRHAGE 143 0.0653
34 PERIPHERAL ARTERY OCCLUSION 91 0.0647
35 ABDOMINAL WALL HAEMATOMA 126 0.0645
36 SUBDURAL HAEMORRHAGE 176 0.0643
37 MALLORY-WEISS SYNDROME 81 0.0638
38 CARDIAC ANEURYSM 63 0.0634
39 INTERMITTENT CLAUDICATION 100 0.0631
40 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 69 0.0627
41 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 88 0.0626
42 ISCHAEMIC CEREBRAL INFARCTION 70 0.0602
43 INTRAVENTRICULAR HAEMORRHAGE 150 0.0602
44 UPPER GASTROINTESTINAL HAEMORRHAGE 1013 0.0602
45 CARDIAC DEATH 72 0.0596
46 DUODENAL ULCER HAEMORRHAGE 169 0.0590
47 PRODUCT MONITORING ERROR 85 0.0588
48 BRAIN NATRIURETIC PEPTIDE INCREASED 180 0.0583
49 ANGIOPLASTY 87 0.0583
50 KOUNIS SYNDROME 130 0.0572
51 ACUTE MYOCARDIAL INFARCTION 1674 0.0567
52 CARDIAC VENTRICULAR THROMBOSIS 73 0.0565
53 SUBDURAL HAEMATOMA 804 0.0561
54 REBOUND ACID HYPERSECRETION 169 0.0558
55 CAROTID ARTERY STENOSIS 193 0.0552
56 SPLENIC RUPTURE 88 0.0535
57 DIVERTICULUM INTESTINAL HAEMORRHAGIC 120 0.0533
58 AORTIC VALVE STENOSIS 95 0.0532
59 NONINFECTIVE GINGIVITIS 77 0.0531
60 OCCULT BLOOD POSITIVE 104 0.0529
61 ACUTE CORONARY SYNDROME 426 0.0514
62 SYSTEMIC INFECTION 85 0.0512
63 MICROCYTIC ANAEMIA 106 0.0509
64 HELICOBACTER GASTRITIS 62 0.0500
65 LOWER GASTROINTESTINAL HAEMORRHAGE 369 0.0499
66 NORMOCYTIC ANAEMIA 73 0.0496
67 ANGINA UNSTABLE 322 0.0495
68 SHOCK HAEMORRHAGIC 399 0.0490
69 CEREBELLAR HAEMORRHAGE 69 0.0483
70 GASTRITIS EROSIVE 224 0.0480
71 POST PROCEDURAL HAEMATOMA 81 0.0480
72 SUBARACHNOID HAEMORRHAGE 486 0.0477
73 CEREBRAL HAEMATOMA 157 0.0467
74 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 190 0.0465
75 PROCEDURAL HAEMORRHAGE 180 0.0460
76 CARDIAC TAMPONADE 214 0.0450
77 VENTRICULAR HYPOKINESIA 143 0.0445
78 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 146 0.0440
79 CORONARY ARTERY OCCLUSION 599 0.0436
80 THROMBOTIC THROMBOCYTOPENIC PURPURA 153 0.0434
81 HAEMATEMESIS 1098 0.0433
82 BRAIN HERNIATION 129 0.0431
83 DYSPNOEA AT REST 124 0.0428
84 ANGINA PECTORIS 1225 0.0427
85 HAEMORRHAGE INTRACRANIAL 634 0.0424
86 PULMONARY ALVEOLAR HAEMORRHAGE 232 0.0413
87 SMALL INTESTINAL HAEMORRHAGE 82 0.0407
88 HAEMOTHORAX 118 0.0406
89 HAEMATOMA 1013 0.0391
90 ECCHYMOSIS 267 0.0389
91 DUODENITIS 119 0.0387
92 GASTRIC HAEMORRHAGE 435 0.0378
93 CORONARY ARTERIAL STENT INSERTION 188 0.0370
94 PLANTAR FASCIITIS 124 0.0369
95 DUODENAL ULCER 259 0.0367
96 BLOOD PRESSURE SYSTOLIC ABNORMAL 90 0.0364
97 INFARCTION 249 0.0364
98 CARDIAC FAILURE CHRONIC 154 0.0361
99 STENOSIS 67 0.0356
100 TACHYARRHYTHMIA 88 0.0352
101 VITREOUS HAEMORRHAGE 96 0.0347
102 ARTERIAL OCCLUSIVE DISEASE 272 0.0346
103 AORTIC ARTERIOSCLEROSIS 89 0.0345
104 CORONARY ARTERY DISEASE 1043 0.0344
105 CEREBRAL HAEMORRHAGE 1233 0.0344
106 OESOPHAGEAL PAIN 136 0.0344
107 END STAGE RENAL DISEASE 625 0.0342
108 ISCHAEMIC CARDIOMYOPATHY 104 0.0339
109 TROPONIN INCREASED 256 0.0336
110 HAEMATURIA 1138 0.0332
111 STENT PLACEMENT 264 0.0327
112 EMBOLIC STROKE 115 0.0326
113 ORTHOPNOEA 102 0.0320
114 LEFT VENTRICULAR DYSFUNCTION 213 0.0318
115 GASTROINTESTINAL HAEMORRHAGE 2645 0.0316
116 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 69 0.0314
117 PERIPHERAL ISCHAEMIA 126 0.0308
118 ATRIAL THROMBOSIS 63 0.0304
119 DIVERTICULUM INTESTINAL 133 0.0304
120 MUSCLE HAEMORRHAGE 122 0.0304
121 CONJUNCTIVAL HAEMORRHAGE 116 0.0303
122 LEFT VENTRICULAR FAILURE 103 0.0299
123 ISCHAEMIC STROKE 533 0.0298
124 COMA SCALE ABNORMAL 86 0.0297
125 RALES 172 0.0296
126 IRON DEFICIENCY ANAEMIA 273 0.0295
127 HAEMORRHAGIC DIATHESIS 105 0.0295
128 DIASTOLIC DYSFUNCTION 91 0.0294
129 OSTEITIS 74 0.0293
130 HAEMORRHAGE SUBCUTANEOUS 103 0.0290
131 MITRAL VALVE INCOMPETENCE 328 0.0289
132 OBSTRUCTIVE AIRWAYS DISORDER 322 0.0289
133 LYMPHOEDEMA 200 0.0289
134 HEMIPARESIS 488 0.0288
135 ANGIOPATHY 161 0.0287
136 LEFT VENTRICULAR HYPERTROPHY 122 0.0285
137 LABYRINTHITIS 72 0.0285
138 HEPARIN-INDUCED THROMBOCYTOPENIA 139 0.0282
139 HAEMORRHAGIC STROKE 220 0.0281
140 MYOCARDIAL ISCHAEMIA 318 0.0279
141 AORTIC STENOSIS 95 0.0273
142 COMPARTMENT SYNDROME 71 0.0272
143 CAROTID ARTERY OCCLUSION 99 0.0271
144 VENTRICULAR FIBRILLATION 298 0.0268
145 INTRACARDIAC THROMBUS 82 0.0267
146 TRANSIENT ISCHAEMIC ATTACK 897 0.0266
147 RECTAL HAEMORRHAGE 1142 0.0266
148 SPINAL CORD COMPRESSION 103 0.0264
149 HAEMATOCHEZIA 1459 0.0264
150 POTENTIATING DRUG INTERACTION 88 0.0262
151 AORTIC VALVE INCOMPETENCE 111 0.0261
152 CHRONIC KIDNEY DISEASE 1979 0.0260
153 CATHETER SITE HAEMORRHAGE 65 0.0260
154 VENTRICULAR ARRHYTHMIA 95 0.0259
155 BUNDLE BRANCH BLOCK LEFT 110 0.0259
156 CARDIOGENIC SHOCK 365 0.0254
157 GASTRIC ULCER HAEMORRHAGE 140 0.0252
158 ABNORMAL LOSS OF WEIGHT 172 0.0252
159 POST PROCEDURAL HAEMORRHAGE 293 0.0251
160 HAEMORRHAGE URINARY TRACT 64 0.0251
161 EXERCISE TOLERANCE DECREASED 144 0.0250
162 ARTERIOSCLEROSIS CORONARY ARTERY 164 0.0247
163 POLYP 162 0.0247
164 RHABDOMYOLYSIS 1031 0.0247
165 CEREBRAL INFARCTION 599 0.0245
166 EUGLYCAEMIC DIABETIC KETOACIDOSIS 101 0.0244
167 PULSELESS ELECTRICAL ACTIVITY 102 0.0244
168 HAEMOPTYSIS 676 0.0242
169 HYPOMAGNESAEMIA 337 0.0242
170 HAEMORRHAGIC ANAEMIA 106 0.0241
171 CIRCULATORY COLLAPSE 409 0.0240
172 WOUND HAEMORRHAGE 88 0.0238
173 FAECES DISCOLOURED 515 0.0237
174 ISCHAEMIA 109 0.0237
175 TRICUSPID VALVE INCOMPETENCE 188 0.0236
176 HEPATIC CYST 80 0.0235
177 HAEMODYNAMIC INSTABILITY 179 0.0235
178 ARTERIOSCLEROSIS 221 0.0235
179 DRUG INTERACTION 3693 0.0233
180 PERIPHERAL VASCULAR DISORDER 119 0.0231
181 HEMIPLEGIA 188 0.0226
182 LOOSE TOOTH 72 0.0223
183 EJECTION FRACTION DECREASED 344 0.0221
184 ARTERIOSPASM CORONARY 88 0.0219
185 HYPOVOLAEMIC SHOCK 104 0.0217
186 CARDIAC FAILURE ACUTE 144 0.0216
187 MYOPATHY 185 0.0214
188 CEREBRAL ISCHAEMIA 110 0.0214
189 ORTHOSTATIC HYPOTENSION 371 0.0213
190 HYPERKALAEMIA 746 0.0213
191 VENTRICULAR TACHYCARDIA 349 0.0211
192 FACIAL PARALYSIS 180 0.0211
193 NEUTROPHILIA 120 0.0211
194 PETECHIAE 220 0.0211
195 ATRIOVENTRICULAR BLOCK FIRST DEGREE 91 0.0210
196 GASTRIC ULCER 398 0.0209
197 HEPATITIS CHOLESTATIC 126 0.0209
198 ACUTE KIDNEY INJURY 3190 0.0208
199 ATRIOVENTRICULAR BLOCK 158 0.0204
200 IMMUNE THROMBOCYTOPENIA 93 0.0203
201 EOSINOPHIL COUNT INCREASED 169 0.0203
202 PEMPHIGOID 152 0.0201
203 MYOCARDIAL INFARCTION 3511 0.0201
204 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 101 0.0199
205 ANAEMIA 3798 0.0199
206 DYSLIPIDAEMIA 101 0.0199
207 EPISTAXIS 1478 0.0197
208 DYSPNOEA EXERTIONAL 743 0.0197
209 BENIGN PROSTATIC HYPERPLASIA 101 0.0195
210 CORONARY ARTERY BYPASS 112 0.0195
211 OESOPHAGEAL ULCER 74 0.0192
212 INFLAMMATORY MARKER INCREASED 95 0.0191
213 PALLOR 521 0.0191
214 BLOOD PRESSURE DIASTOLIC DECREASED 140 0.0189
215 ANURIA 163 0.0189
216 MUSCLE RUPTURE 73 0.0187
217 ABDOMINAL TENDERNESS 92 0.0185
218 PURPURA 163 0.0184
219 FEMORAL NECK FRACTURE 94 0.0183
220 SENSATION OF FOREIGN BODY 154 0.0183
221 SKIN ABRASION 86 0.0182
222 HAEMORRHAGE 1891 0.0181
223 MOUTH HAEMORRHAGE 132 0.0180
224 HYDROCEPHALUS 98 0.0180
225 EOSINOPHILIA 314 0.0179
226 ATRIOVENTRICULAR BLOCK COMPLETE 118 0.0176
227 BLOOD PRESSURE INADEQUATELY CONTROLLED 106 0.0176
228 PROSTATOMEGALY 69 0.0175
229 BLOOD PRESSURE SYSTOLIC DECREASED 79 0.0174
230 HAEMOGLOBIN DECREASED 1781 0.0173
231 HIATUS HERNIA 224 0.0173
232 OESOPHAGITIS 188 0.0172
233 GLOMERULAR FILTRATION RATE DECREASED 210 0.0171
234 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 65 0.0170
235 BRADYCARDIA 896 0.0169
236 GASTRITIS 444 0.0169
237 HAEMORRHOIDAL HAEMORRHAGE 82 0.0168
238 PULMONARY HAEMORRHAGE 131 0.0167
239 HYPONATRAEMIA 940 0.0167
240 NEUTROPENIC SEPSIS 119 0.0166
241 GINGIVAL BLEEDING 227 0.0166
242 DIVERTICULUM 118 0.0166
243 CARDIAC FAILURE 1327 0.0165
244 GROIN PAIN 145 0.0165
245 CREATININE RENAL CLEARANCE DECREASED 66 0.0165
246 FAECALOMA 90 0.0164
247 INCREASED TENDENCY TO BRUISE 150 0.0163
248 MYOSITIS 145 0.0161
249 ANEURYSM 80 0.0161
250 ELECTROCARDIOGRAM ABNORMAL 126 0.0160
251 BLOOD PRESSURE SYSTOLIC INCREASED 313 0.0160
252 ESCHERICHIA URINARY TRACT INFECTION 68 0.0160
253 INTERNATIONAL NORMALISED RATIO INCREASED 456 0.0160
254 HYPOGLYCAEMIA 772 0.0159
255 ACUTE PULMONARY OEDEMA 89 0.0158
256 PERICARDIAL EFFUSION 366 0.0158
257 VITAMIN B12 DEFICIENCY 64 0.0158
258 INTESTINAL ISCHAEMIA 87 0.0158
259 CATHETERISATION CARDIAC 70 0.0158
260 AORTIC ANEURYSM 120 0.0158
261 EXOSTOSIS 143 0.0156
262 MOUTH SWELLING 90 0.0156
263 LACTIC ACIDOSIS 504 0.0155
264 PROTHROMBIN TIME PROLONGED 93 0.0155
265 URINE OUTPUT DECREASED 135 0.0154
266 RESPIRATORY RATE INCREASED 137 0.0154
267 CHOLECYSTITIS ACUTE 87 0.0153
268 DIZZINESS POSTURAL 148 0.0152
269 SYNCOPE 1527 0.0152
270 SLEEP APNOEA SYNDROME 290 0.0152
271 INCREASED UPPER AIRWAY SECRETION 78 0.0152
272 CONTRAINDICATED PRODUCT ADMINISTERED 457 0.0151
273 ATRIAL FIBRILLATION 1468 0.0151
274 AORTIC DISSECTION 62 0.0150
275 PRESYNCOPE 362 0.0149
276 SUPRAVENTRICULAR TACHYCARDIA 140 0.0146
277 APHASIA 439 0.0145
278 GANGRENE 87 0.0144
279 ACUTE RESPIRATORY FAILURE 275 0.0143
280 DRUG RESISTANCE 366 0.0142
281 RENAL CYST 113 0.0142
282 POLYARTHRITIS 75 0.0142
283 SINUS BRADYCARDIA 137 0.0142
284 DRUG-INDUCED LIVER INJURY 443 0.0141
285 CEREBROVASCULAR ACCIDENT 2388 0.0141
286 UROSEPSIS 129 0.0140
287 DYSARTHRIA 525 0.0139
288 HAEMARTHROSIS 124 0.0138
289 CACHEXIA 71 0.0138
290 EMBOLISM 114 0.0137
291 RENAL INJURY 406 0.0137
292 BLOOD CHOLESTEROL ABNORMAL 63 0.0136
293 PRODUCT PRESCRIBING ERROR 324 0.0136
294 APLASTIC ANAEMIA 71 0.0136
295 LARGE INTESTINE POLYP 94 0.0136
296 GENERAL PHYSICAL HEALTH DETERIORATION 1570 0.0136
297 ATRIAL FLUTTER 108 0.0135
298 COLITIS MICROSCOPIC 64 0.0135
299 BLOOD CREATINE PHOSPHOKINASE INCREASED 389 0.0135
300 BUNDLE BRANCH BLOCK RIGHT 62 0.0135
301 CYSTITIS 430 0.0135
302 CARDIAC ARREST 1109 0.0134
303 ELECTROLYTE IMBALANCE 156 0.0134
304 BLOOD POTASSIUM INCREASED 218 0.0134
305 HYPOTENSION 2693 0.0134
306 DIABETES MELLITUS INADEQUATE CONTROL 237 0.0134
307 RENAL FAILURE 1776 0.0134
308 RENAL FAILURE ACUTE 565 0.0133
309 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 136 0.0132
310 HYPOCALCAEMIA 250 0.0132
311 SECRETION DISCHARGE 165 0.0132
312 HEART RATE DECREASED 460 0.0131
313 HYPERNATRAEMIA 65 0.0130
314 CONTUSION 1248 0.0130
315 TORSADE DE POINTES 101 0.0129
316 CHEST PAIN 2384 0.0129
317 HYPOKALAEMIA 594 0.0129
318 ANAL INCONTINENCE 115 0.0128
319 HAEMATOCRIT DECREASED 253 0.0127
320 HYPERLIPIDAEMIA 152 0.0127
321 NECROSIS 70 0.0126
322 RENAL TUBULAR NECROSIS 123 0.0125
323 PERIPHERAL COLDNESS 172 0.0125
324 AUTOIMMUNE HEPATITIS 87 0.0125
325 PNEUMOTHORAX 198 0.0125
326 COAGULOPATHY 208 0.0125
327 BLOOD PRESSURE FLUCTUATION 298 0.0124
328 CHOLESTASIS 238 0.0124
329 CARDIAC OPERATION 106 0.0123
330 TRANSFUSION 129 0.0123
331 POSTOPERATIVE WOUND INFECTION 82 0.0121
332 EYE HAEMORRHAGE 161 0.0121
333 RENAL IMPAIRMENT 1001 0.0119
334 INTERNAL HAEMORRHAGE 136 0.0119
335 NEPHROPATHY 111 0.0119
336 HEAD INJURY 375 0.0118
337 SPUTUM DISCOLOURED 112 0.0118
338 BLOOD PRESSURE DECREASED 779 0.0117
339 PRODUCT ADMINISTRATION ERROR 236 0.0117
340 RETINAL HAEMORRHAGE 83 0.0116
341 BLOOD UREA INCREASED 195 0.0116
342 HYPERCHOLESTEROLAEMIA 112 0.0116
343 ARRHYTHMIA 549 0.0116
344 NOCTURIA 140 0.0115
345 HALLUCINATION 869 0.0115
346 CONCOMITANT DISEASE AGGRAVATED 71 0.0115
347 FLANK PAIN 107 0.0114
348 COORDINATION ABNORMAL 159 0.0114
349 GOUT 204 0.0114
350 CARDIAC DISORDER 1063 0.0114
351 ULCER HAEMORRHAGE 76 0.0112
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 585 0.0112
353 CONFUSIONAL STATE 1810 0.0112
354 CARDIAC VALVE DISEASE 64 0.0112
355 URINARY RETENTION 373 0.0112
356 HALLUCINATION, VISUAL 236 0.0112
357 PRODUCT ODOUR ABNORMAL 117 0.0112
358 BRAIN OEDEMA 141 0.0112
359 MYOCLONUS 133 0.0111
360 PULMONARY HYPERTENSION 232 0.0111
361 SKIN ULCER 287 0.0111
362 OEDEMA PERIPHERAL 1353 0.0111
363 BLOOD CREATININE INCREASED 724 0.0111
364 HYPERTENSIVE CRISIS 123 0.0110
365 RENAL FAILURE CHRONIC 85 0.0110
366 SWOLLEN TONGUE 344 0.0110
367 FALL 3661 0.0110
368 OLIGURIA 68 0.0109
369 BLOOD CALCIUM DECREASED 123 0.0109
370 TOXIC SKIN ERUPTION 110 0.0109
371 LIVER FUNCTION TEST ABNORMAL 316 0.0109
372 PULMONARY OEDEMA 486 0.0108
373 SKIN LACERATION 118 0.0108
374 TUBULOINTERSTITIAL NEPHRITIS 203 0.0108
375 HYPERTHYROIDISM 156 0.0108
376 HYPOVOLAEMIA 63 0.0108
377 ELECTROCARDIOGRAM QT PROLONGED 386 0.0107
378 HAEMOGLOBIN ABNORMAL 69 0.0107
379 SKIN HAEMORRHAGE 158 0.0106
380 CARDIOMEGALY 131 0.0106
381 PRESCRIBED UNDERDOSE 212 0.0106
382 MEDICATION ERROR 590 0.0106
383 SPINAL OSTEOARTHRITIS 93 0.0106
384 BLINDNESS TRANSIENT 78 0.0106
385 BLOOD MAGNESIUM DECREASED 91 0.0105
386 PLATELET COUNT INCREASED 137 0.0105
387 OXYGEN SATURATION DECREASED 587 0.0104
388 CLOSTRIDIUM DIFFICILE COLITIS 110 0.0104
389 BODY TEMPERATURE DECREASED 102 0.0104
390 ESCHERICHIA INFECTION 85 0.0103
391 CARDIAC FAILURE CONGESTIVE 830 0.0103
392 BLOOD URINE PRESENT 196 0.0103
393 BLOOD SODIUM DECREASED 194 0.0103
394 DRUG ADMINISTRATION ERROR 315 0.0103
395 CHEST DISCOMFORT 1051 0.0103
396 PLEURAL EFFUSION 621 0.0102
397 CARDIOVASCULAR DISORDER 259 0.0102
398 SHOCK 234 0.0102
399 HEPATITIS ACUTE 66 0.0101
400 LIP SWELLING 337 0.0101
401 LOW DENSITY LIPOPROTEIN INCREASED 78 0.0101
402 LUNG INFILTRATION 89 0.0101
403 HYPERGLYCAEMIA 367 0.0101
404 BALANCE DISORDER 869 0.0100
405 WOUND 280 0.0100
406 TACHYPNOEA 136 0.0100
407 HYPOKINESIA 144 0.0099
408 VENTRICULAR EXTRASYSTOLES 103 0.0099
409 FLUID RETENTION 504 0.0099
410 UNRESPONSIVE TO STIMULI 255 0.0099
411 GASTROOESOPHAGEAL REFLUX DISEASE 795 0.0099
412 METABOLIC ACIDOSIS 315 0.0098
413 DELIRIUM 341 0.0098
414 HAEMODIALYSIS 82 0.0098
415 JOINT DISLOCATION 103 0.0097
416 MOUTH ULCERATION 205 0.0097
417 BLOOD PRESSURE ABNORMAL 193 0.0097
418 TOOTH FRACTURE 107 0.0097
419 SENSORY LOSS 78 0.0097
420 DYSURIA 356 0.0097
421 DYSPNOEA 5468 0.0096
422 MULTIPLE ORGAN DYSFUNCTION SYNDROME 273 0.0096
423 JAUNDICE 259 0.0096
424 FIBROMYALGIA 233 0.0096
425 MYALGIA 1615 0.0095
426 ANGIOEDEMA 420 0.0095
427 HEAD DISCOMFORT 168 0.0095
428 EXTRASYSTOLES 66 0.0094
429 PARKINSONISM 92 0.0094
430 ASPHYXIA 77 0.0094
431 ACIDOSIS 72 0.0094
432 ADRENAL INSUFFICIENCY 114 0.0094
433 SUDDEN DEATH 99 0.0093
434 COLITIS ISCHAEMIC 63 0.0093
435 PULMONARY MASS 139 0.0093
436 DIARRHOEA HAEMORRHAGIC 87 0.0093
437 CHROMATURIA 210 0.0093
438 PRODUCTIVE COUGH 444 0.0093
439 HEART RATE IRREGULAR 210 0.0093
440 PULMONARY CONGESTION 122 0.0092
441 DEPRESSED LEVEL OF CONSCIOUSNESS 365 0.0092
442 MUSCULAR WEAKNESS 1048 0.0092
443 PHARYNGITIS 114 0.0092
444 HICCUPS 75 0.0091
445 ATELECTASIS 88 0.0091
446 DERMATITIS BULLOUS 65 0.0090
447 LOCALISED INFECTION 217 0.0090
448 THROMBOCYTOPENIA 1003 0.0090
449 WHEEZING 530 0.0089
450 PSYCHIATRIC SYMPTOM 65 0.0088
451 HYPOPHAGIA 225 0.0088
452 ASTHENIA 3307 0.0088
453 BLOOD IRON DECREASED 104 0.0088
454 BRONCHOSPASM 125 0.0088
455 ORAL DISORDER 64 0.0087
456 LETHARGY 501 0.0087
457 HYPOXIA 305 0.0087
458 TINNITUS 395 0.0086
459 COLD SWEAT 151 0.0086
460 AGITATION 628 0.0085
461 PULMONARY FIBROSIS 164 0.0085
462 THROMBOSIS 687 0.0085
463 DIZZINESS 4258 0.0085
464 DYSPEPSIA 837 0.0085
465 PERIPHERAL SWELLING 1301 0.0084
466 DEMENTIA 236 0.0084
467 POST PROCEDURAL COMPLICATION 162 0.0084
468 TENDON RUPTURE 104 0.0084
469 MALNUTRITION 94 0.0084
470 ABDOMINAL PAIN 1953 0.0084
471 LEUKOCYTOSIS 151 0.0083
472 TENDON PAIN 63 0.0083
473 CHOLECYSTITIS 99 0.0083
474 ASPIRATION 91 0.0083
475 RESPIRATORY DISTRESS 228 0.0083
476 DISORIENTATION 327 0.0082
477 INCONTINENCE 87 0.0082
478 CYANOSIS 129 0.0082
479 PROSTATIC SPECIFIC ANTIGEN INCREASED 113 0.0082
480 URINARY INCONTINENCE 243 0.0082
481 LOSS OF CONSCIOUSNESS 1049 0.0082
482 ABDOMINAL PAIN LOWER 207 0.0082
483 DEHYDRATION 1086 0.0081
484 COVID-19 PNEUMONIA 96 0.0081
485 EMPHYSEMA 82 0.0081
486 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 63 0.0081
487 POLYNEUROPATHY 97 0.0081
488 MUSCULOSKELETAL PAIN 424 0.0081
489 BLOOD ALBUMIN DECREASED 64 0.0081
490 BODY HEIGHT DECREASED 86 0.0080
491 OSTEOPENIA 122 0.0080
492 DYSPHONIA 470 0.0080
493 RESPIRATORY FAILURE 584 0.0080
494 BACTERIAL INFECTION 149 0.0080
495 VERTIGO 485 0.0079
496 IMPAIRED GASTRIC EMPTYING 108 0.0079
497 DRUG PRESCRIBING ERROR 152 0.0079
498 GASTROINTESTINAL PAIN 87 0.0079
499 BRONCHITIS 585 0.0079
500 HYPERTENSION 1673 0.0079
501 MENTAL STATUS CHANGES 219 0.0079
502 TENDONITIS 122 0.0079
503 SKIN LESION 216 0.0079
504 CARDIAC MURMUR 68 0.0079
505 ERUCTATION 152 0.0078
506 THROMBOTIC MICROANGIOPATHY 76 0.0078
507 COUGH 2179 0.0078
508 VASCULITIS 90 0.0077
509 PNEUMONIA ASPIRATION 193 0.0077
510 HAEMOLYTIC ANAEMIA 69 0.0077
511 DECREASED APPETITE 1787 0.0077
512 CELLULITIS 385 0.0076
513 MULTI-ORGAN FAILURE 132 0.0076
514 OEDEMA 414 0.0076
515 BLOOD POTASSIUM DECREASED 229 0.0076
516 DECUBITUS ULCER 62 0.0076
517 SPEECH DISORDER 398 0.0076
518 THIRST 135 0.0075
519 LOWER RESPIRATORY TRACT INFECTION 343 0.0075
520 BLOOD PRESSURE INCREASED 1153 0.0075
521 PNEUMONIA 2440 0.0075
522 RIB FRACTURE 155 0.0075
523 SPLENOMEGALY 88 0.0075
524 SPINAL PAIN 88 0.0075
525 HAEMORRHOIDS 146 0.0075
526 TENDERNESS 78 0.0075
527 GASTROENTERITIS 109 0.0075
528 CARDIOMYOPATHY 110 0.0074
529 URINARY TRACT INFECTION 1267 0.0074
530 ATAXIA 88 0.0074
531 INTERSTITIAL LUNG DISEASE 359 0.0074
532 HEPATOCELLULAR INJURY 105 0.0074
533 LIMB INJURY 201 0.0074
534 HYPERHIDROSIS 952 0.0074
535 SEPSIS 824 0.0074
536 PYELONEPHRITIS 64 0.0074
537 AGRANULOCYTOSIS 137 0.0074
538 PARALYSIS 105 0.0073
539 SINUS TACHYCARDIA 104 0.0073
540 CARDIO-RESPIRATORY ARREST 306 0.0073
541 C-REACTIVE PROTEIN INCREASED 266 0.0073
542 HOSPICE CARE 72 0.0073
543 DIVERTICULITIS 202 0.0073
544 RETINAL DETACHMENT 67 0.0073
545 DIPLOPIA 189 0.0073
546 MOTOR DYSFUNCTION 74 0.0073
547 PRURITUS GENERALISED 157 0.0073
548 NERVE COMPRESSION 67 0.0073
549 BLOOD ALKALINE PHOSPHATASE INCREASED 180 0.0072
550 TRANSAMINASES INCREASED 161 0.0072
551 ASCITES 212 0.0072
552 PANCYTOPENIA 403 0.0072
553 GAIT DISTURBANCE 1379 0.0072
554 MUSCLE TWITCHING 166 0.0072
555 MOBILITY DECREASED 515 0.0072
556 ALTERED STATE OF CONSCIOUSNESS 155 0.0071
557 DERMATITIS ALLERGIC 90 0.0071
558 SEPTIC SHOCK 311 0.0071
559 ORAL PAIN 160 0.0071
560 DECREASED ACTIVITY 77 0.0071
561 HEPATIC STEATOSIS 132 0.0071
562 ABDOMINAL PAIN UPPER 1456 0.0071
563 NECK PAIN 395 0.0071
564 BLOOD TEST ABNORMAL 99 0.0070
565 DYSPHAGIA 668 0.0070
566 INTERVERTEBRAL DISC DEGENERATION 65 0.0070
567 LACERATION 66 0.0070
568 TASTE DISORDER 142 0.0070
569 EATING DISORDER 149 0.0070
570 TREATMENT NONCOMPLIANCE 382 0.0070
571 GAMMA-GLUTAMYLTRANSFERASE INCREASED 154 0.0069
572 MASS 97 0.0069
573 CONSTIPATION 1510 0.0069
574 BASAL CELL CARCINOMA 108 0.0069
575 TYPE 2 DIABETES MELLITUS 233 0.0069
576 HEPATIC CIRRHOSIS 130 0.0069
577 BLOOD TRIGLYCERIDES INCREASED 122 0.0069
578 DEVICE OCCLUSION 97 0.0069
579 EYE PAIN 388 0.0069
580 SOPOR 91 0.0069
581 MUSCLE ATROPHY 87 0.0069
582 FEEDING DISORDER 139 0.0068
583 NIGHTMARE 237 0.0068
584 MUSCLE SPASMS 1256 0.0068
585 POLLAKIURIA 285 0.0068
586 TACHYCARDIA 606 0.0068
587 HYPOTHERMIA 69 0.0068
588 ERECTILE DYSFUNCTION 175 0.0068
589 GLYCOSYLATED HAEMOGLOBIN INCREASED 172 0.0068
590 SKIN DISCOLOURATION 313 0.0068
591 BLOOD COUNT ABNORMAL 103 0.0068
592 DRUG LEVEL INCREASED 112 0.0068
593 RASH MACULO-PAPULAR 150 0.0067
594 ULCER 107 0.0067
595 PAIN IN EXTREMITY 1979 0.0067
596 CLOSTRIDIUM DIFFICILE INFECTION 146 0.0067
597 MUSCULOSKELETAL DISCOMFORT 115 0.0067
598 COMA 318 0.0067
599 HERNIA 129 0.0067
600 DRUG ERUPTION 118 0.0067
601 WEIGHT DECREASED 1858 0.0066
602 ERYTHEMA MULTIFORME 62 0.0066
603 DYSSTASIA 194 0.0066
604 IMPAIRED HEALING 218 0.0066
605 DIALYSIS 94 0.0066
606 WHITE BLOOD CELL COUNT INCREASED 254 0.0066
607 DISSEMINATED INTRAVASCULAR COAGULATION 93 0.0066
608 OSTEOARTHRITIS 280 0.0066
609 PHOTOSENSITIVITY REACTION 109 0.0066
610 LIVER INJURY 162 0.0066
611 NEPHROPATHY TOXIC 74 0.0066
612 PANCREATITIS ACUTE 147 0.0065
613 BODY TEMPERATURE INCREASED 133 0.0065
614 CATARACT 388 0.0065
615 AMNESIA 423 0.0065
616 DELUSION 101 0.0065
617 PALPITATIONS 760 0.0065
618 ARTHRITIS 509 0.0065
619 CHOLELITHIASIS 212 0.0065
620 TOOTHACHE 117 0.0065
621 OSTEOMYELITIS 117 0.0065
622 DIARRHOEA 4157 0.0064
623 THERAPY NON-RESPONDER 288 0.0064
624 WOUND INFECTION 70 0.0064
625 HYPERBILIRUBINAEMIA 66 0.0064
626 SINUS CONGESTION 86 0.0064
627 SEASONAL ALLERGY 90 0.0064
628 BACK PAIN 1476 0.0063
629 MALAISE 2784 0.0063
630 LUNG DISORDER 311 0.0063
631 COGNITIVE DISORDER 296 0.0063
632 HYPOTONIA 63 0.0063
633 ALANINE AMINOTRANSFERASE INCREASED 387 0.0063
634 LIMB DISCOMFORT 195 0.0063
635 PRODUCT SUBSTITUTION ISSUE 362 0.0063
636 ABDOMINAL DISTENSION 654 0.0063
637 FLATULENCE 355 0.0063
638 FATIGUE 4849 0.0062
639 MICTURITION URGENCY 71 0.0062
640 DEPRESSED MOOD 328 0.0062
641 TEMPERATURE INTOLERANCE 64 0.0062
642 BLINDNESS 252 0.0062
643 BURSITIS 75 0.0062
644 SLUGGISHNESS 63 0.0062
645 ORAL CANDIDIASIS 81 0.0061
646 DYSKINESIA 250 0.0061
647 BLOOD CHOLESTEROL INCREASED 286 0.0061
648 AGEUSIA 153 0.0061
649 RENAL PAIN 65 0.0061
650 FLUID OVERLOAD 89 0.0061
651 LUNG INFECTION 95 0.0061
652 MUCOSAL INFLAMMATION 160 0.0061
653 HIP FRACTURE 196 0.0061
654 DIABETIC KETOACIDOSIS 146 0.0061
655 MUSCULOSKELETAL CHEST PAIN 94 0.0061
656 JOINT SWELLING 731 0.0060
657 RED BLOOD CELL COUNT DECREASED 173 0.0060
658 VISION BLURRED 828 0.0060
659 WEIGHT FLUCTUATION 63 0.0060
660 RESTLESSNESS 220 0.0060
661 POOR VENOUS ACCESS 62 0.0060
662 DRY MOUTH 485 0.0060
663 CONDITION AGGRAVATED 1814 0.0060
664 BLISTER 335 0.0060
665 RASH PRURITIC 323 0.0060
666 BLINDNESS UNILATERAL 84 0.0059
667 INTERVERTEBRAL DISC PROTRUSION 130 0.0059
668 ABDOMINAL DISCOMFORT 995 0.0059
669 RENAL DISORDER 276 0.0059
670 RESPIRATORY DISORDER 177 0.0059
671 DIABETES MELLITUS 451 0.0059
672 PHARYNGEAL OEDEMA 91 0.0059
673 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 152 0.0059
674 SEROTONIN SYNDROME 113 0.0059
675 SCAB 67 0.0059
676 PULMONARY ARTERIAL HYPERTENSION 85 0.0059
677 GENERALISED TONIC-CLONIC SEIZURE 97 0.0059
678 HYPERSOMNIA 168 0.0059
679 PARANOIA 101 0.0059
680 FEELING COLD 163 0.0058
681 COLON CANCER 87 0.0058
682 HEART RATE INCREASED 577 0.0058
683 JOINT RANGE OF MOTION DECREASED 78 0.0058
684 VOMITING 2734 0.0058
685 FACE OEDEMA 98 0.0058
686 MYELODYSPLASTIC SYNDROME 84 0.0058
687 ORAL DISCOMFORT 80 0.0058
688 BRAIN FOG 90 0.0057
689 BACTERAEMIA 68 0.0057
690 RESPIRATORY TRACT INFECTION 149 0.0057
691 DEAFNESS 149 0.0057
692 BURNING SENSATION 399 0.0057
693 SWELLING FACE 370 0.0057
694 LEUKOPENIA 284 0.0057
695 RASH GENERALISED 147 0.0057
696 MUSCULOSKELETAL DISORDER 108 0.0057
697 NERVOUS SYSTEM DISORDER 177 0.0057
698 MOVEMENT DISORDER 182 0.0057
699 RHINORRHOEA 365 0.0056
700 GAIT INABILITY 187 0.0056
701 BLOOD BILIRUBIN INCREASED 151 0.0056
702 PAIN IN JAW 157 0.0055
703 ASPARTATE AMINOTRANSFERASE INCREASED 294 0.0055
704 PARAESTHESIA 868 0.0055
705 PNEUMONITIS 150 0.0055
706 HALLUCINATION, AUDITORY 87 0.0055
707 HEPATITIS 140 0.0055
708 HOT FLUSH 412 0.0055
709 TREMOR 907 0.0055
710 STEVENS-JOHNSON SYNDROME 121 0.0054
711 HEPATOTOXICITY 121 0.0054
712 SOMNOLENCE 1091 0.0054
713 PROTEINURIA 103 0.0054
714 CANDIDA INFECTION 91 0.0054
715 COLITIS 204 0.0054
716 RETCHING 114 0.0053
717 ECONOMIC PROBLEM 81 0.0053
718 PLATELET COUNT DECREASED 569 0.0053
719 RASH ERYTHEMATOUS 255 0.0053
720 BONE DISORDER 97 0.0053
721 FULL BLOOD COUNT DECREASED 107 0.0053
722 DEPRESSION 1206 0.0053
723 SWELLING 496 0.0053
724 PRURITUS 2035 0.0053
725 PARAESTHESIA ORAL 76 0.0053
726 HYPERCALCAEMIA 65 0.0053
727 NEUROPATHY PERIPHERAL 500 0.0053
728 SEIZURE 607 0.0052
729 INFLAMMATION 271 0.0052
730 MUSCULOSKELETAL STIFFNESS 460 0.0052
731 BEDRIDDEN 69 0.0052
732 ARTHRALGIA 2179 0.0052
733 SPINAL FRACTURE 105 0.0052
734 VISUAL IMPAIRMENT 648 0.0052
735 DISTURBANCE IN ATTENTION 281 0.0052
736 ACUTE RESPIRATORY DISTRESS SYNDROME 92 0.0052
737 ACUTE HEPATIC FAILURE 71 0.0052
738 SENSORY DISTURBANCE 83 0.0052
739 RESTLESS LEGS SYNDROME 94 0.0052
740 EPILEPSY 158 0.0052
741 ANOREXIA 66 0.0051
742 HYPOAESTHESIA 765 0.0051
743 INTENTIONAL PRODUCT USE ISSUE 447 0.0051
744 SLEEP DISORDER 360 0.0051
745 SCIATICA 81 0.0051
746 STOMATITIS 308 0.0051
747 MEMORY IMPAIRMENT 697 0.0051
748 TOXIC EPIDERMAL NECROLYSIS 77 0.0051
749 RESPIRATORY TRACT CONGESTION 80 0.0050
750 FRACTURE 95 0.0050
751 GASTROINTESTINAL DISORDER 449 0.0050
752 TOOTH INFECTION 66 0.0050
753 NEUTROPHIL COUNT DECREASED 204 0.0050
754 NAUSEA 3954 0.0050
755 BLOOD LACTATE DEHYDROGENASE INCREASED 79 0.0050
756 ANAPHYLACTIC REACTION 275 0.0050
757 FEELING HOT 305 0.0050
758 BLOOD GLUCOSE INCREASED 932 0.0049
759 ASTHMA 559 0.0049
760 HEPATIC FUNCTION ABNORMAL 184 0.0049
761 HYPOACUSIS 210 0.0049
762 MIDDLE INSOMNIA 91 0.0049
763 RASH MACULAR 170 0.0049
764 VISUAL ACUITY REDUCED 161 0.0048
765 HEPATIC FAILURE 146 0.0048
766 DRUG DISPENSING ERROR 74 0.0048
767 NEPHROLITHIASIS 222 0.0048
768 SKIN CANCER 103 0.0048
769 ABASIA 118 0.0048
770 THERAPY INTERRUPTED 340 0.0048
771 RESPIRATORY ARREST 131 0.0047
772 THROAT IRRITATION 213 0.0047
773 COMPLETED SUICIDE 392 0.0047
774 HYPOTHYROIDISM 150 0.0047
775 POOR QUALITY SLEEP 101 0.0047
776 GLOSSODYNIA 105 0.0047
777 FEELING ABNORMAL 1122 0.0047
778 AGGRESSION 233 0.0047
779 NEURALGIA 113 0.0046
780 MUSCLE TIGHTNESS 75 0.0046
781 PULMONARY EMBOLISM 439 0.0046
782 CHOKING 90 0.0046
783 LIVER FUNCTION TEST INCREASED 99 0.0046
784 NEUTROPENIA 624 0.0046
785 HEADACHE 2871 0.0046
786 CARPAL TUNNEL SYNDROME 64 0.0046
787 NIGHT SWEATS 147 0.0046
788 BLOOD GLUCOSE DECREASED 219 0.0046
789 BLOOD GLUCOSE ABNORMAL 84 0.0045
790 OSTEOPOROSIS 187 0.0045
791 SKIN REACTION 64 0.0045
792 THERAPY CESSATION 233 0.0045
793 INTESTINAL OBSTRUCTION 171 0.0045
794 PRODUCT DOSE OMISSION 295 0.0045
795 INTENTIONAL DOSE OMISSION 127 0.0045
796 METASTASES TO LIVER 78 0.0044
797 LACRIMATION INCREASED 134 0.0044
798 PYREXIA 1532 0.0044
799 DRUG INTOLERANCE 423 0.0044
800 ERYTHEMA 899 0.0044
801 EAR PAIN 85 0.0044
802 BONE PAIN 255 0.0043
803 INSOMNIA 1158 0.0043
804 ANAPHYLACTIC SHOCK 112 0.0043
805 DISEASE RECURRENCE 205 0.0043
806 URTICARIA 720 0.0043
807 ENCEPHALOPATHY 105 0.0043
808 RASH 1859 0.0043
809 FLUSHING 433 0.0043
810 CHILLS 499 0.0043
811 DEEP VEIN THROMBOSIS 276 0.0042
812 OROPHARYNGEAL PAIN 393 0.0042
813 SKIN DISORDER 141 0.0042
814 ANHEDONIA 111 0.0042
815 JOINT INJURY 90 0.0042
816 HERPES ZOSTER 242 0.0042
817 ANXIETY 1190 0.0042
818 KIDNEY INFECTION 82 0.0042
819 NASAL CONGESTION 245 0.0042
820 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 200 0.0042
821 INFLUENZA 462 0.0041
822 MULTIPLE FRACTURES 68 0.0041
823 GASTRIC DISORDER 142 0.0041
824 ANKLE FRACTURE 64 0.0041
825 PRODUCT AVAILABILITY ISSUE 94 0.0041
826 LIVER DISORDER 183 0.0041
827 SKIN EXFOLIATION 348 0.0041
828 NASOPHARYNGITIS 759 0.0041
829 FOOT FRACTURE 78 0.0041
830 EYE DISORDER 135 0.0041
831 GLAUCOMA 79 0.0041
832 INFECTION 592 0.0041
833 PRODUCT DOSE OMISSION IN ERROR 115 0.0041
834 LOWER LIMB FRACTURE 78 0.0041
835 PAIN 2482 0.0040
836 PRESCRIBED OVERDOSE 78 0.0040
837 THINKING ABNORMAL 75 0.0040
838 THYROID DISORDER 62 0.0040
839 PERITONITIS 83 0.0040
840 EYE SWELLING 149 0.0040
841 TOOTH DISORDER 89 0.0040
842 ARTHROPATHY 222 0.0040
843 THROAT TIGHTNESS 108 0.0040
844 PHOTOPHOBIA 75 0.0040
845 INTENTIONAL PRODUCT MISUSE 348 0.0040
846 UPPER LIMB FRACTURE 79 0.0040
847 MENTAL IMPAIRMENT 96 0.0040
848 PRODUCT USE IN UNAPPROVED INDICATION 978 0.0039
849 TOXICITY TO VARIOUS AGENTS 665 0.0039
850 PRODUCT USE COMPLAINT 62 0.0039
851 DRY EYE 196 0.0039
852 HEPATIC ENZYME INCREASED 267 0.0039
853 OBESITY 62 0.0039
854 OFF LABEL USE 3406 0.0039
855 ABNORMAL DREAMS 107 0.0039
856 PRODUCT DISPENSING ERROR 84 0.0039
857 LABORATORY TEST ABNORMAL 113 0.0038
858 DYSGEUSIA 283 0.0038
859 OSTEONECROSIS OF JAW 94 0.0038
860 PSYCHOMOTOR HYPERACTIVITY 63 0.0038
861 PANIC ATTACK 138 0.0038
862 COVID-19 660 0.0038
863 GYNAECOMASTIA 116 0.0037
864 UPPER RESPIRATORY TRACT INFECTION 173 0.0037
865 FEBRILE NEUTROPENIA 248 0.0037
866 LYMPHADENOPATHY 132 0.0037
867 JOINT STIFFNESS 97 0.0037
868 SINUS DISORDER 73 0.0037
869 FEMUR FRACTURE 114 0.0037
870 DISCOMFORT 224 0.0037
871 ECZEMA 192 0.0037
872 OCULAR HYPERAEMIA 173 0.0036
873 VIRAL INFECTION 121 0.0036
874 PANCREATITIS 192 0.0036
875 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
876 GASTROENTERITIS VIRAL 65 0.0036
877 FREQUENT BOWEL MOVEMENTS 97 0.0036
878 SNEEZING 80 0.0036
879 WEIGHT INCREASED 793 0.0035
880 ACTIVITIES OF DAILY LIVING IMPAIRED 70 0.0035
881 PRODUCT USE ISSUE 663 0.0035
882 DEATH 3010 0.0035
883 PRODUCT PRESCRIBING ISSUE 76 0.0035
884 HOSPITALISATION 536 0.0035
885 HYPERSENSITIVITY 646 0.0035
886 SKIN FISSURES 68 0.0035
887 PSYCHOTIC DISORDER 102 0.0035
888 CONJUNCTIVITIS 64 0.0034
889 MIGRAINE 328 0.0034
890 SINUSITIS 350 0.0034
891 NERVOUSNESS 178 0.0034
892 STAPHYLOCOCCAL INFECTION 111 0.0034
893 ACCIDENTAL OVERDOSE 123 0.0034
894 MENTAL DISORDER 146 0.0034
895 ILLNESS 345 0.0033
896 BONE MARROW FAILURE 68 0.0033
897 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 183 0.0033
898 FUNGAL INFECTION 111 0.0033
899 ORAL HERPES 65 0.0033
900 EYE IRRITATION 189 0.0033
901 UNEVALUABLE EVENT 248 0.0033
902 THERAPEUTIC RESPONSE DECREASED 195 0.0032
903 WHITE BLOOD CELL COUNT DECREASED 348 0.0032
904 ABNORMAL BEHAVIOUR 126 0.0032
905 INFLUENZA LIKE ILLNESS 260 0.0032
906 SURGERY 185 0.0032
907 DERMATITIS 66 0.0031
908 INTENTIONAL OVERDOSE 202 0.0031
909 DRUG INEFFECTIVE 4134 0.0031
910 PRODUCT DOSE OMISSION ISSUE 920 0.0031
911 IRRITABLE BOWEL SYNDROME 67 0.0031
912 RASH PAPULAR 70 0.0031
913 INFUSION RELATED REACTION 207 0.0031
914 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 562 0.0031
915 TOOTH LOSS 64 0.0031
916 PAIN OF SKIN 83 0.0031
917 EAR INFECTION 81 0.0030
918 PSORIATIC ARTHROPATHY 123 0.0030
919 DISEASE PROGRESSION 357 0.0030
920 DRUG EFFECT INCOMPLETE 109 0.0030
921 DRY SKIN 397 0.0030
922 LUNG NEOPLASM MALIGNANT 122 0.0030
923 SEDATION 77 0.0029
924 IRRITABILITY 176 0.0029
925 PSORIASIS 380 0.0029
926 RHEUMATOID ARTHRITIS 327 0.0029
927 INJECTION SITE BRUISING 229 0.0029
928 ANGER 97 0.0029
929 PLASMA CELL MYELOMA 110 0.0028
930 UNDERDOSE 203 0.0028
931 ROAD TRAFFIC ACCIDENT 116 0.0028
932 EYE PRURITUS 93 0.0028
933 THERAPEUTIC RESPONSE UNEXPECTED 123 0.0027
934 CONVULSION 156 0.0027
935 FEAR 73 0.0027
936 ADVERSE DRUG REACTION 243 0.0027
937 SUICIDE ATTEMPT 164 0.0027
938 SUICIDAL IDEATION 247 0.0027
939 INJECTION SITE MASS 98 0.0026
940 MOOD ALTERED 72 0.0026
941 ILL-DEFINED DISORDER 160 0.0026
942 DRUG DOSE OMISSION 424 0.0026
943 OVERDOSE 544 0.0025
944 INJURY 177 0.0025
945 PROCEDURAL PAIN 69 0.0025
946 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 176 0.0025
947 ALOPECIA 476 0.0024
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 491 0.0024
949 THERAPEUTIC RESPONSE SHORTENED 80 0.0024
950 INJECTION SITE HAEMORRHAGE 190 0.0024
951 PROSTATE CANCER 191 0.0024
952 INCORRECT DOSE ADMINISTERED 532 0.0023
953 MALIGNANT NEOPLASM PROGRESSION 237 0.0023
954 EXPIRED PRODUCT ADMINISTERED 76 0.0023
955 WITHDRAWAL SYNDROME 94 0.0022
956 VAGINAL HAEMORRHAGE 93 0.0021
957 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 152 0.0021
958 NEEDLE ISSUE 62 0.0021
959 TREATMENT FAILURE 176 0.0021
960 NEOPLASM PROGRESSION 73 0.0021
961 ADVERSE EVENT 190 0.0021
962 PRODUCT QUALITY ISSUE 269 0.0020
963 COLITIS ULCERATIVE 88 0.0020
964 SKIN IRRITATION 90 0.0020
965 THERAPEUTIC PRODUCT EFFECT DECREASED 87 0.0019
966 EMOTIONAL DISTRESS 223 0.0018
967 EXTRA DOSE ADMINISTERED 74 0.0018
968 NEOPLASM MALIGNANT 121 0.0018
969 CRYING 62 0.0017
970 DRUG EFFECT DECREASED 90 0.0017
971 SKIN BURNING SENSATION 113 0.0016
972 INJECTION SITE PAIN 482 0.0016
973 DEVICE ISSUE 137 0.0015
974 MULTIPLE SCLEROSIS 71 0.0015
975 DERMATITIS ATOPIC 72 0.0014
976 INJECTION SITE PRURITUS 91 0.0014
977 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
978 INJECTION SITE SWELLING 100 0.0013
979 DEVICE MALFUNCTION 89 0.0013
980 EXPOSURE DURING PREGNANCY 77 0.0012
981 INJECTION SITE ERYTHEMA 150 0.0012
982 DEVICE DIFFICULT TO USE 74 0.0011
983 MATERNAL EXPOSURE DURING PREGNANCY 99 0.0011
984 NO ADVERSE EVENT 187 0.0010
985 INJECTION SITE REACTION 71 0.0010
986 ACNE 77 0.0010
987 DRUG ABUSE 78 0.0009
988 ACCIDENTAL EXPOSURE TO PRODUCT 96 0.0009
989 PRODUCT STORAGE ERROR 81 0.0009
990 DRUG DOSE OMISSION BY DEVICE 66 0.0008
991 BREAST CANCER 77 0.0008
992 FOETAL EXPOSURE DURING PREGNANCY 64 0.0008
993 DRUG WITHDRAWAL SYNDROME 62 0.0007